Vemurafenib in Melanoma with BRAF V600E Mutation

  • Chapman, Paul B. M.D.
  • Hauschild, Axel M.D.
  • McArthur, Grant A. M.B., B.S., Ph.D.

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY [email protected]

    2University of Kiel, Kiel, Germany

    3Peter MacCallum Cancer Center, Melbourne, VIC, Australia

Since publication of their article, the authors report no further potential conflict of interest.

New England Journal of Medicine 365(15):p 1450, October 13, 2011.
Copyright © 2011 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF